| Heading: |
Genomics: China |
| Question ID: |
1743259 |
| UIN: |
15377 |
| House: |
Commons |
| Date tabled: |
2024-11-20 |
| Asking Member ID: |
5351 |
| Asking Member display name: |
Gregory Stafford
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Gregory Stafford
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether he has had discussions with (a) Cabinet colleagues, (b) Genomics England, (c) UK Biobank and (d) NIHR BioResource on (i) BGI Group, (ii) MGI Tech and (iii) other state-linked genomics compa |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-11-28 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Through the delivery of the UK Biological Security Strategy, the Government is committed to ensuring the United Kingdom is resilient to a spectrum of biological threats, as well as being a world leader in innovation. As part of this strategy, the Governme... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |